DIVITUM Trademark

Trademark Overview


On Wednesday, April 13, 2022, a trademark application was filed for DIVITUM with the United States Patent and Trademark Office. The USPTO has given the DIVITUM trademark a serial number of 79344278. The federal status of this trademark filing is REGISTERED as of Tuesday, August 8, 2023. This trademark is owned by Biovica International AB. The DIVITUM trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Diagnostic agents and reagents, preparations and substances for medical and veterinary purposes for the measurement of cell division; diagnostic agents and reagents, preparations and substances for measuring enzyme activity for medical and veterinary purposes; diagnostic kits comprised of medical diagnostic reagents and biomarker assays to monitor and predict treatment response in cancer therapy; diagnostic kits comprised of medical diagnostic reagents and biomarker assays to monitor and predict treatment response in viral diseases; diagnostic kits comprised of medical diagnostic reagents and biomarker assays to monitor and predict treatment response in autoimmune diseases

Diagnostic preparations for scientific or research use; diagnostic agents and reagents for scientific or research use

Medical, biomedical and veterinary diagnostic monitoring and testing services regarding blood serum or plasma samples or cell cultures; medical, biomedical and veterinary diagnostic monitoring and testing services regarding measurement of cell proliferation; medical, biomedical and veterinary diagnostic monitoring and testing services regarding measurement of enzymatic activity; provision of medical information and advice relating to the use of medical and veterinary diagnostic equipment; medical testing for diagnostic or treatment purposes, namely, conducting tests to identify diseases affecting cell division, cancer, viral and autoimmune diseases; medical analysis regarding the identification and monitoring of cancer, virus and autoimmune diseases and other diseases that cause cell growth for the diagnosis and treatment of persons

Scientific laboratory services and scientific research and analysis regarding monitoring and predicting treatment response to cancer therapy, and in viral therapy and autoimmune therapy; scientific laboratory services and research and analysis regarding measuring the activity of enzyme in blood serum or cell cultures; research and development in the field of diagnostic preparations; scientific research and development, namely, diagnostic development; data science services, namely, compiling data for research purposes in the field of biostatistics; laboratory biomarker analysis services and related data analysis; biochemical analysis; medical laboratory services; conducting preclinical studies in the nature of scientific feasibility studies; medical laboratory services regarding measurement of cell division; conducting scientific feasibility studies, namely, preclinical studies regarding measurement of cell proliferation; medical laboratory services regarding measurement of enzymatic ac...
divitum

General Information


Serial Number79344278
Word MarkDIVITUM
Filing DateWednesday, April 13, 2022
Status700 - REGISTERED
Status DateTuesday, August 8, 2023
Registration Number7129071
Registration DateTuesday, August 8, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 23, 2023

Trademark Statements


Goods and ServicesDiagnostic agents and reagents, preparations and substances for medical and veterinary purposes for the measurement of cell division; diagnostic agents and reagents, preparations and substances for measuring enzyme activity for medical and veterinary purposes; diagnostic kits comprised of medical diagnostic reagents and biomarker assays to monitor and predict treatment response in cancer therapy; diagnostic kits comprised of medical diagnostic reagents and biomarker assays to monitor and predict treatment response in viral diseases; diagnostic kits comprised of medical diagnostic reagents and biomarker assays to monitor and predict treatment response in autoimmune diseases
Goods and ServicesDiagnostic preparations for scientific or research use; diagnostic agents and reagents for scientific or research use
Goods and ServicesMedical, biomedical and veterinary diagnostic monitoring and testing services regarding blood serum or plasma samples or cell cultures; medical, biomedical and veterinary diagnostic monitoring and testing services regarding measurement of cell proliferation; medical, biomedical and veterinary diagnostic monitoring and testing services regarding measurement of enzymatic activity; provision of medical information and advice relating to the use of medical and veterinary diagnostic equipment; medical testing for diagnostic or treatment purposes, namely, conducting tests to identify diseases affecting cell division, cancer, viral and autoimmune diseases; medical analysis regarding the identification and monitoring of cancer, virus and autoimmune diseases and other diseases that cause cell growth for the diagnosis and treatment of persons
Goods and ServicesScientific laboratory services and scientific research and analysis regarding monitoring and predicting treatment response to cancer therapy, and in viral therapy and autoimmune therapy; scientific laboratory services and research and analysis regarding measuring the activity of enzyme in blood serum or cell cultures; research and development in the field of diagnostic preparations; scientific research and development, namely, diagnostic development; data science services, namely, compiling data for research purposes in the field of biostatistics; laboratory biomarker analysis services and related data analysis; biochemical analysis; medical laboratory services; conducting preclinical studies in the nature of scientific feasibility studies; medical laboratory services regarding measurement of cell division; conducting scientific feasibility studies, namely, preclinical studies regarding measurement of cell proliferation; medical laboratory services regarding measurement of enzymatic activity; conducting scientific feasibility studies, namely, preclinical studies regarding measurement of enzymatic activity

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, July 8, 2022
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 8, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 8, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 8, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBiovica International AB
Party Type30 - Original Registrant
Legal Entity Type64 - NOT AVAILABLE
AddressSE

Party NameBiovica International AB
Party Type20 - Owner at Publication
Legal Entity Type64 - NOT AVAILABLE
AddressSE

Party NameBiovica International AB
Party Type10 - Original Applicant
Legal Entity Type64 - NOT AVAILABLE
AddressSE

Trademark Events


Event DateEvent Description
Monday, November 13, 2023FINAL DISPOSITION NOTICE SENT TO IB
Monday, November 13, 2023FINAL DISPOSITION PROCESSED
Wednesday, November 8, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 8, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 8, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, May 24, 2023NOTIFICATION PROCESSED BY IB
Tuesday, May 23, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 23, 2023PUBLISHED FOR OPPOSITION
Wednesday, May 3, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, May 3, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, May 3, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 20, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 20, 2023REFUSAL PROCESSED BY IB
Friday, April 14, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 13, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 13, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 6, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 6, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, April 6, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, April 6, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 6, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 29, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, March 29, 2023REFUSAL PROCESSED BY MPU
Friday, February 3, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, February 2, 2023NON-FINAL ACTION WRITTEN
Tuesday, January 31, 2023ASSIGNED TO EXAMINER
Monday, October 24, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 24, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 24, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, October 24, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 24, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 24, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, October 10, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 10, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 10, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, October 10, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 10, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 10, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sunday, September 18, 2022NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, July 12, 2022APPLICATION FILING RECEIPT MAILED
Friday, July 8, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 7, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB